Clinical Trial Update: A Study of Epoetin Beta (NeoRecormon) in Predialysis Patients With Renal Anemia [Phase 4]

View source ↗

Summary

Phase 4 study of epoetin beta (NeoRecormon) in predialysis patients with renal anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• Epoetin Beta (NeoRecormon) (epoetin beta)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 4 | Status: COMPLETED